Specifically, the N501Y mutation has been strongly associated with elevated plasma levels of tPA, aPTT, and D-dimer, highlighting its potential role in the pathogenesis of COVID-19-related thrombosis (Hadid et al., 2021; Kalbhenn et al., 2021). Here, PLAT is linked to COVID-19.